Skip to content

Association Between Periodontitis and the Level of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis

Association Between Severity of Periodontitis and the Level of Anti-citrullinated Protein Antibodies (ACPAs) in Rheumatoid Arthritis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05706493
Enrollment
62
Registered
2023-01-31
Start date
2024-03-01
Completion date
2025-02-01
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases, Rheumatoid Arthritis

Keywords

periodontitis, rheumatoid arthritis, anti citrullinated protein antibodies, peptidyl arginine deminase enzyme, gingival crevicular fluid (GCF)

Brief summary

the relationship between rheumatoid arthritis and periodontal disease is crucial and has been explained via a complex interplay of genetic, environmental, and hormonal factors that influence the host immune tolerance leading to both disease characteristics. The aim of this study is to clinically investigate the correlation between the levels of anti-citrullinated protein antibodies (ACPAs) in gingival crevicular fluid and the severity of periodontal disease and rheumatoid arthritis in rheumatoid arthritis (RA) patients

Detailed description

the relationship between rheumatoid arthritis and periodontal disease is crucial and has been explained via a complex interplay of genetic, environmental, and hormonal factors that influence the host immune tolerance leading to both disease characteristics. The aim of this study is to clinically investigate the correlation between the levels of anti-citrullinated protein antibodies (ACPAs) in gingival crevicular fluid and the severity of periodontal disease and rheumatoid arthritis in rheumatoid arthritis (RA) patients Materials and Methods: a total of 62 participants suffering from periodontitis and rheumatoid arthritis will be referred from the Badr Hospital (Faculty of Medicine, Helwan University) to Misr international university's dental clinic complex. Gingival crevicular fluid (GCF) samples will be collected from the patients . Assessment of ACPAs will be quantified using enzyme-linked immunoassay (ELISA) as the primary outcome Assessment of 2ry outcomes includes clinical periodontal and RA parameters

Interventions

None listed

Sponsors

Misr International University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rheumatoid patients fulfilling the ACR criteria for the classification of RA * 18 years * Both genders * Presence of at least 8 teeth

Exclusion criteria

* Smoking * Diabetes Mellitus * Pregnant females * Patients who had undergone periodontal treatment within last 3 months * Antibiotic therapy during last 3 months * Other autoimmune diseases

Design outcomes

Primary

MeasureTime frameDescription
the level of anti-citrullinated protein antibodies (ACPAs)Baselineassessment of the level of anti-citrullinated protein antibodies (ACPAs) in gingival crevicular fluid

Secondary

MeasureTime frameDescription
Clinical attachment LossBaselinemeasuring the distance from the cemento enamel junction to the base of the pocket in mm
Probing depthBaselinemeasuring the distance from the gingival margin to the base of the pocket in mm

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORZainab Hafez, Lecturer

Lecturer, faculty of oral and dental medicine misr international university

PRINCIPAL_INVESTIGATORYahia Hassan, Lecturer

Lecturer, faculty of oral and dental medicine misr international university

STUDY_DIRECTORShahinaz Al ashiry, asso.Prof

Associate Professor, faculty of oral and dental medicine misr international universit

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026